ABI1 and prostate neoplasm: Dysregulated ABI1 in prostate tumors is linked to abnormal cell adhesion leading to prostatic intraepithelial neoplasia, characterized by increased AKT activation and decreased levels of E-cadherin, β-catenin, and WAVE2 [125].